Testosterone
| Testosterone | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 288.40 g/mol [1] |
| Appearance | White needles from dilute acetone [1] |
| Odor | Odorless [1] |
| Melting point | 155 °C [1] |
| Decomposition | When heated to decomposition it emits acrid smoke and irritating fumes. [1] |
| Solubility | 23.4 mg/L (at 25 °C) [1] |
| Predicted LogP | 3.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C19H28O2 |
| IUPAC name | (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
| SMILES | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C |
| InChI | InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1 |
| InChIKey | MUMGGOZAMZWBJJ-DYKIIFRCSA-N |
| CAS number | 58-22-0 |
| UNII | 3XMK78S47O |
| PubChem CID | 6013 |
Testosterone (also known as Virosterone, Homosterone, Mertestate, Testim, Testosteron, Androderm, Androlin, Sustanon, Testiculosterone or Orquisteron) is a androgen, hormone and steroid substance of the steroid class.
Chemistry
Stereochemistry []
Testosterone is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Testosterone matches Lipinski's rule of five.Pharmacology
ATC Classification
- genito urinary system and sex hormones (G)
- sex hormones and modulators of the genital system (G03)
- androgens (G03B)
- 3-oxoandrosten (4) derivatives (G03BA)
- (G03BA03)
- testosterone (G03BA03)
MeSH Classification
- androgens (M0001106)
Mechanism of action []
The androgen receptor exists in the cytoplasm bound to the heat shock proteins HSP90, HSP70, and other chaperones. After binding to an androgen, the androgen receptor dissociates from HSP90 and undergoes a conformational change to slow the rate of dissociation from the androgen receptor. The androgen-receptor complex is transported into the nucleus where it binds to DNA and recruits other transcriptional regulators to form a pre-initiation complex and eventually induce expression of specific genes. Testosterone and its active metabolite dihydrotestosterone (DHT) act as an agonist of the androgen receptor to activate the receptor and upregulate the expression of androgen receptors, promoting the development of masculine sex organs including the prostate, seminal vesicles, penis, and scrotum. Agonism of the androgen receptor is also responsible for the development of secondary sexual characteristics including facial and body hair, enlargement of the larynx, thickening of the vocal cords, and changes in muscle and fat distribution. [1]
Medical side effects []
374 side effects listed on drug labels in SIDER 4.1 (testosterone).
- Application site pruritus
- Blister
- Dermatitis bullous
- Vesiculobullous rash
- Thermal burn
- Prostatomegaly
- Stomatitis
- Mouth ulceration
- Buccal inflammation
- Application site irritation
- Back pain
- Laboratory test abnormal
- Application site vesicles
- Injection site pain
- Dysgeusia
- Bad taste
- Application site reaction
- Dermatitis contact
- Haematocrit increased
- Application site erythema
- Diarrhoea
- Prostatic disorder
- Vomiting
- Induration
- Acne
- Application site pain
- Application site burn
- Prostatic specific antigen increased
- Hypogonadism
- Oestradiol increased
- Anaemia
- Gastrointestinal haemorrhage
- Gingival swelling
- Gingival oedema
- Haemoglobin increased
- Pruritus
- Testicular disorder
- Dry skin
- Application site induration
- Ejaculation disorder
- Injection site erythema
- Hypertension
- Red blood cell count increased
- Prostate cancer
- Application site rash
- Depression
- Gynaecomastia
- Headache
- Breast pain
- Mood swings
- Affect lability
- Blood pressure increased
- Prostate induration
- Benign prostatic hyperplasia
- Benign prostatic hypertrophy
- Pain
- Stinging
- Pelvic pain
- Urinary tract infection
- Vertigo
- Peripheral vascular disorder
- Lacrimation increased
- Lacrimation
- Blood pressure diastolic decreased
- Spontaneous penile erection
- Confusional state
- Feeling abnormal
- Malaise
- Urinary incontinence
- Growth accelerated
- Increased appetite
- Abdominal pain
- Abdominal cramps
- Gastrointestinal pain
- Aggression
- Alopecia
- Amnesia
- Anaphylactic shock
- Anaphylactoid reaction
- Anger
- Angina pectoris
- Angioedema
- Anxiety
- Arthralgia
- Musculoskeletal discomfort
- Myalgia
- Asthenia
- Fatigue
- Asthma
- Mental disorder
- Breast disorder
- Cerebral infarction
- Transient ischaemic attack
- Chest pain
- Chest discomfort
- Infection
- Connective tissue disorder
- Cough
- Cyst
- Sudden hearing loss
- Libido decreased
- Disturbance in sexual arousal
- Libido increased
- Dermatitis atopic
- Diabetes mellitus
- Dizziness
- Syncope
- Dyspnoea
- Dysuria
- Urination impaired
- Strangury
- Oedema
- Endocrine disorder
- Epididymitis
- Dermatitis
- Rash
- Eye disorder
- Gastrointestinal disorder
- Cardiac arrest
- Cardiac disorder
- Cardiac failure
- Haematuria
- Hirsutism
- Hostility
- Hypercholesterolaemia
- Hyperhidrosis
- Sweating
- Sweating increased
- Hyperlipidaemia
- Hyperparathyroidism
- Hypersensitivity
- Hypertriglyceridaemia
- Blood triglycerides increased
- Hyperventilation
- Hypoglycaemia
- Hypokalaemia
- Immune system disorder
- Incontinence
- Irritability
- Hepatic neoplasm
- Chronic obstructive pulmonary disease
- Bronchial hyperreactivity
- Systemic lupus erythematosus
- Mediastinal disorder
- Musculoskeletal pain
- Myocardial infarction
- Acute coronary syndrome
- Nausea
- Neoplasm
- Nervous system disorder
- Nervousness
- Tension
- Nocturia
- Azoospermia
- Osteopenia
- Osteoporosis
- Pain in extremity
- Paraesthesia
- Paresthesia generalized
- Peliosis hepatis
- Personality disorder
- Polycythaemia
- Polyp
- Priapism
- Prostatitis
- Male orgasmic disorder
- Precocious puberty
- Pulmonary embolism
- Rhinitis
- Seborrhoeic dermatitis
- Shock
- Sleep apnoea syndrome
- Snoring
- Spermatocele
- Cerebrovascular accident
- Swelling
- Loss of consciousness
- Tachycardia
- Testicular pain
- Thrombocytopenia
- Embolism
- Embolism venous
- Venous thromboembolism
- Thrombosis
- Tinnitus
- Erythema
- Pollakiuria
- Micturition urgency
- Urethral disorder
- Urinary tract disorder
- Urticaria
- Varicocele
- Angiopathy
- Vasodilation procedure
- Venous insufficiency
- Virilism
- Vitreous detachment
- Weight increased
- Dry mouth
- Urinary retention
- Urogenital disorder
- Agitation
- Hyperkinesia
- Oedema peripheral
- Deep vein thrombosis
- Migraine
- Injection site abscess
- Gamma-glutamyltransferase increased
- Hair colour changes
- High density lipoprotein decreased
- Injection site reaction
- Liver function test abnormal
- Coronary artery occlusion
- Rash pustular
- Aspartate aminotransferase increased
- Alanine aminotransferase increased
- Urinary hesitation
- Renal colic
- Testicular atrophy
- Enlarged clitoris
- Androgenetic alopecia
- Malnutrition
- Skin disorder
- Discomfort
- Ill-defined disorder
- Abdominal pain upper
- Tenderness
- Intraocular pressure increased
- Pharyngeal oedema
- Lip swelling
- Prostate infection
- Blood testosterone decreased
- Serum testosterone decreased
- Cerebrovascular insufficiency
- Erectile dysfunction
- Hepatobiliary disease
- Fluid retention
- Generalised oedema
- Wernicke-Korsakoff syndrome
- Breast induration
- Glucose tolerance impaired
- Prostatic dysplasia
- Blood bilirubin increased
- Bilirubin total increased
- Atrophy
- Cognitive disorder
- Nephrolithiasis
- Transaminases increased
- Urine flow decreased
- Respiratory distress
- Musculoskeletal chest pain
- Pulmonary microemboli
- Injection site irritation
- Influenza like illness
- Injection site haematoma
- Surgery
- Renal pain
- Blood glucose increased
- Menopausal symptoms
- Hot flush
- Erythropoiesis abnormal
- Abdominal symptom
- Infestation
- Administration site reaction
- Sleep disorder
- Blood testosterone increased
- Blood prolactin increased
- Laryngeal pain
- Insomnia
- Injection site discomfort
- Free prostate-specific antigen increased
- Prostate examination abnormal
- Rash papular
- Dysphonia
- Procedural pain
- Coronary artery disease
- Pulmonary oil microembolism
- Leukocytoclastic vasculitis
- Amenorrhoea
- Appetite disorder
- Arthritis
- Coagulopathy
- Breast cyst
- Bronchitis
- Neoplasm malignant
- Contusion
- Diplopia
- Eczema
- Folliculitis
- Gastrooesophageal reflux disease
- Gingival recession
- Gingivitis
- Haemarthrosis
- Haemorrhage
- Haemoglobin
- Hyperaesthesia
- Nipple pain
- Inflammation
- Jaundice cholestatic
- Leukoplakia
- Nasal congestion
- Nasal oedema
- Nasopharyngitis
- Palpitations
- Penis disorder
- Pneumonia
- Polyuria
- Urine output increased
- Neoplasm prostate
- Pruritus genital
- Renal failure
- Rosacea
- Serum sickness
- Sinusitis
- Toothache
- Ulcer
- Upper respiratory tract infection
- Chills
- Hepatic function abnormal
- Oral disorder
- Blood creatinine increased
- Epiphyses premature fusion
- Renal impairment
- Prothrombin level increased
- Hypogeusia
- Skin irritation
- Menstruation irregular
- Depression suicidal
- Hair growth abnormal
- Disturbance in attention
- Clitoral engorgement
- Abnormal dreams
- Dermatitis acneiform
- Application site oedema
- Ocular hyperaemia
- Throat tightness
- Gingival pain
- Irritation gum
- Activated partial thromboplastin time prolonged
- Vulvovaginal burning sensation
- Breast tenderness
- Soft tissue disorder
- Cheilitis
- Lip pain
- Lip ulceration
- Blood pressure systolic increased
- Haemoglobin abnormal
- Nipple disorder
- Blood urea normal
- Penile pain
- Prostatic adenoma
- Paraesthesia oral
- Affective disorder
- Dissociation
- Lipids abnormal
- Balance disorder
- Blood cholesterol increased
- International normalised ratio increased
- Buccal mucosal roughening
- Lipids increased
- Application site warmth
- Application site dryness
- Abnormal clotting factor
- Gingival erythema
- Gingival blister
- Impatience
- Gastrointestinal hypomotility
- Epidermal necrosis
- Sensitisation
- Parosmia
- Application site exfoliation
- Breast enlargement
- Hepatic cancer
- Hepatocellular carcinoma
Indications
- Anaphylactic shock
- Application site erythema
- Application site irritation
- Breast cancer
- Cryptorchism
- Delayed puberty
- Depressed mood
- Dermatitis contact
- Dry skin
- Erectile dysfunction
- Erythema
- Fatigue
- Hypoactive sexual desire disorder
- Hypogonadism
- Hypogonadism male
- Klinefelter's syndrome
- Libido decreased
- Menopause
- Neoplasm
- Orchitis
- Primary hypogonadism
- Prostatic specific antigen increased
- Pruritus
- Puberty
- Pulmonary oil microembolism
- Redness
- Secondary hypogonadism
- Serum testosterone decreased
- Skin irritation
- Testosterone deficiency
- Trauma
Experience reports
Erowid
There are currently 10 experience reports involving testosterone on Erowid: []- "Gear of the Gods" by Juicedbrah
- "I Tried Putting Some Under My Tongue" by some guy
- "My Anabolic Frolic" by lysergamind
- "Fitness Enhancer" by billiam
- "I Would Take Charge" by Bojack
- "Mind Altering Effects" by Mike
- "Have Some Good Information Before Starting" by Why_em
- "Me and Steroids" by swiy
- "Felt a Little Less Drowsy" by Angelo W.
- "Horniness & Erections Came Back" by Z._Woornivp
- "I Have Tried Every Single Drug and Steroid" by Hangeth_Thy_Dong (51 upvotes)
- "2g Lemon Tek Report" by mambyjamby (6 upvotes)
- "I made a mistake for my first DMT breakthrough." by DependentEcstatic883 (5 upvotes)
- "110mg+78mg MDMA + Weed Bongs . THERAPY IN A CRYSTAL FORM . First Proper Roll" by SouthAfricanDiscoFan (0 upvotes)
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 6013, Testosterone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/6013
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Testosterone. UNII: 3XMK78S47O. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3XMK78S47O
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 04:56:21 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 04:56:17 |
| erowid | ok | 2026-11-20 04:56:19 |
| gsrs | ok | 2026-11-20 04:56:17 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0000234) | 2026-11-20 04:56:17 |
| kegg | ok | 2026-11-20 04:56:19 |
| pubchem | ok | 2026-11-20 04:56:17 |
| ok | 2026-11-20 04:56:17 | |
| sider | ok | 2026-11-20 04:56:18 |
| structure | ok | 2026-11-20 04:56:17 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 04:56:18 |